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 Abstract 
 
In rational drug design, the most effective targets are identified when a 
mechanism-based understanding of a disease state’s proliferation and 
persistence is available. 2-amino-α-carboline (2-AαC) is a heterocyclic 
aromatic amine (HAA), which upon metabolic activation in vivo, can covalently 
bind to the C8-position of guanine. This modification elicits a response from 
the Nucleotide Excision Repair (NER) system but, if left unrepaired, may result 
in mutations. The metabolites of 2-AαC are significantly more reactive towards 
adduct formation than those of 4-aminobiphenyl (4-ABP), a confirmed human 
bladder carcinogen. Furthermore, 2-AαC is found in cigarette smoke at 
concentrations 1000 times greater than 4-ABP. 2-AαC has been implicated in 
hepatocellular carcinoma and cancers of the gastrointestinal tract, potentially 
explaining the increased incidence of liver cancer in smokers. The cause of 
cancers and many other diseases is attributed to DNA mutations caused by 
failure of a cell’s natural DNA repair mechanisms. NER is a major human 
repair system among many, all part of a complex network consisting of 
hundreds of proteins that target different types of damage. The overlapping 
systems making up this network are dependent on molecular recognition and 
signaling pathways.  
 
Structural and thermodynamic investigations of abnormal DNA duplexes have 
yielded valuable mechanism-based information for use in drug discovery. To 
 perform these studies, the DNA lesion in question must be readily available. 
Despite powerful implications regarding the role of 2-AαC in cancer, efficient 
synthetic protocols are not available for 2-AαC or the corresponding adducts. 
Inefficient biomimetic production of C8-(2-AαC)-guanine adducts has been 
reported, but is limited by scale and sequence context. This project outlines a 
more efficient synthesis of 2-AαC and novel analogs necessary for certain 
structural investigations. Attempts to synthesize a C8-(2-AαC)-guanine 
oligonucleotide are also described to provide a starting point for future 
investigations. 
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 1 
1. Introduction 
 
In average human cells, DNA damage occurs over 10,000 times per day1. 
DNA damage is defined as a chemical alteration to a base, sugar, or 
phosphate backbone2. Accurate transcription and replication is dependent on 
molecular recognition. Depending on the extent and nature of the damage, if 
left unrepaired, it may disrupt transcription or result in heritable mutations 
during replication. Select examples of DNA damage are shown in figure 1. 
 
Figure 1: Different types of DNA damage elicit responses from a variety of 
repair systems. 
Oxidative	Damage 
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In order to maintain genome integrity, cells have evolved a complex network of 
overlapping DNA repair systems composed of hundreds of proteins3. The 
nature of the chemical alteration will determine which repair system(s), if any, 
will respond to the change4. Failure of repair systems to fix damaged DNA is 
cited as a major contributing factor to cancers, aging, and other serious 
disorders5.  
 
The broad role of Nucleotide Excision Repair (NER) makes the mechanisms of 
NER a target of interest in medical research6. NER responds to bulky adducts 
that cause global structural changes in the damaged duplex7. Common 
substrates for the NER pathway include adducts formed by polycyclic aromatic 
hydrocarbons (PAH) and aromatic amines6,7. Figure 2 shows various adducts 
of aromatic amines and heterocyclic aromatic amines (HAA). Biochemical 
response can vary widely between these adducts indicating that minor 
changes in DNA structure can drastically alter outcomes. 
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Figure 2: Adducts of aromatic amines and HAA’s 
 
The relationship between structure, thermodynamics, and function cannot be 
overstated. Figure 3 displays a general overview of thermodynamic 
parameters that contribute to DNA structure and emphasizes the importance 
of these investigations. 
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Figure 3: (1) Thermodynamic contributions of non-covalent interactions 
determine stability, structure, and activity of DNA. (2) Thermodynamic 
parameters determine macromolecular structure and groove dynamics. (3) 
How do modifications to DNA affect the stability, and structure? 
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Adducts that alter DNA structure may change the location, orientation, or 
strength of non-covalent interactions and, as a result, may impact global DNA 
conformation. Depending on the location, mutagenicity, and repair efficacy of 
the adduct, the alteration can have major implications on biological function. 
The relationship between structure, thermodynamics, and function that has 
already been discussed means biological phenomenon, such as the 
mutagenicity and repair efficacy of DNA adducts, can be investigated by 
measuring changes in the thermodynamic profile of a model duplex. 
 
Figure 4: For illustrative purposes only. Protein (A) is binding to DNA (B) at 
different sites. Modification to a DNA base can 1) alter groove dynamics, 
changing the global shape of the duplex and impact binding and 2) the 
modification can physically block the binding site. 
 
A 
B 
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As has already been established, DNA adducts cause aberrant biochemical 
events that can result in cancer initiation8,9. While some exposure to aromatic 
amines is largely unavoidable, knowledge of environmental hazards can help 
mitigate risk. Adduct formation and mutagenicity are independent variables, 
thus specific properties of an aromatic amine can impact adduct formation but 
not mutagenicity and vice versa7. In other words, it is possible for adducts to 
have a high rate of formation and a high rate of repair. In this case, the 
number of mutations per adduct formed will be low. Delineating the 
mechanism of adduct-formation, and how cells respond to them, increases the 
likelihood of successful medical interventions after exposure has occurred. 
 
Adduct formation with respect to NER substrates usually requires bio 
activation10. Cytochrome P450 (CYP for specific subfamilies, or P450 for the 
enzyme family) is a major metabolic enzyme for aromatic compounds such as 
PAHs and HAAs11. The amine compounds in figure 2 are characteristic 
substrates for various CYP isoforms that catalyze enzymatic redox reactions 
whereby amine groups are partially oxidized to the reactive N-hydroxyl (figure 
5). 
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Figure 5: Metabolism of aromatic amines by P450 produces reactive 
electrophiles that form adducts with nucleophillic sites on DNA (d). Redox 
reactions a, b, and c are reversible by separte P450 isoforms and in different 
oxidation states of the enzymes. 
 
The efficiency of NER is dependent on the thermodynamic favorability of 
binding events between the DNA adduct and repair proteins6. If the adduct is 
not repaired in a timely manner, mutations may occur during the next round of 
replication. Depending on the nature and location of the mutation along with 
other variables, this can result in cancer7,9. Delineating these mechanisms is, 
by definition, a necessary step in rational drug design12,13. Structural, 
thermodynamic, and kinetic properties that describe biochemical events are an 
essential foundation for developing drug targets13–16 
 
2-Amino-α-carboline (2-AαC, figures 2 and 6) is an adduct-forming HAA 
implicated in hepatocellular carcinoma and GI tract cancers17–19. The 
suspected carcinogen is present in cigarette smoke and overcooked meat at 
concentrations greater than other confirmed animal carcinogens17–20. Although 
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factors other than adduct formation are involved in cancer initiation, a causal 
relationship has been established between adduct formation and mutation9. 
 
Figure 6: General structure and numbering scheme of carbolines. 
 
4-Aminobiphenyl (4-ABP, figure 2) is a confirmed human bladder carcinogen 
present in cigarette smoke at concentrations ranging from 0.1 - 4.3 
ng/cigarette18. Highly reactive electrophiles resulting from the metabolic 
activation of 4-ABP as outlined in figure 5 help to explain the increased 
incidence of bladder cancer among cigarette smokers. However, the increased 
incidence of gastrointestinal tract and liver cancers is largely unexplained. 
 
Uridine 5'-diphospho-glucuronosyltransferase (UGT) is a phase II metabolic 
liver enzyme that catalyzes a glucuronidation reaction marking the metabolite 
for excretion. 2-AαC undergoes secondary metabolism in the liver by UGT and 
produces metabolites that are significantly more reactive towards the 
formation of DNA adducts than the activated species of 4-ABP20(figure 7).  
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Figure 7: Metabolism of 2-AαC. 2-AαC is a pyrolysis product of protein and 
can be found when protein is exposed to heat, including grilled meat. It also 
ungergoes UGT secondary metabolism where the bulky leaving group 
increases reactivity. 
 
Furthermore, 2-AαC is present in cigarette smoke at a concentration ranging 
from 60 – 258 ng/cigarette, 1000 times greater than 4-ABP18. There is also a 
positive correlation between smoking and 2-AαC concentration in urine21. 
Taken together, this provides a probable explanation for the increased 
incidence of GI tract and liver cancer in smokers. 
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Despite reports implicating 2-AαC in various human cancers, there are no 
studies available describing the structural, thermodynamic or kinetic properties 
of 2-AαC adducts. The value of this data is significant in drug development.12 
Currently, there is not an efficient synthetic protocol for 2-AαC and its 
corresponding C8-guanosine adduct described in literature. This is probably 
due to its relatively recent implication in human cancers. 
 
DNA replication and repair is dependent on molecular recognition, the 
principles of which are based on structural and thermodynamic parameters 
within the system. The conformation of a DNA adduct will impact any 
biochemical process in which the adduct is involved, such as replication and 
repair14. Data that describes the nature and magnitude of structural and 
conformational changes induced by aromatic amines will provide insight as to 
how those parameters influence replication and repair proteins.  
 
Bulky adducts of environmental aromatic amines, including HAAs, are known 
to exist in two major conformations: S- and B-conformers (figure 8)7. The S 
conformer disrupts Watson Crick base pairing between the modified 
nucleoside and its complementary base, placing the carcinogen inside the 
duplex where it slip-stacks with the neighboring bases. The B conformer 
maintains Watson Crick base pairing with an anti glycosidic modified dG, 
placing the carcinogen in the spacious major groove. As stacking ability of the 
carcinogen increases, the enthalpic contribution of the Watson Crick base pair 
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is reduced relative to the enthalpic considerations of stacking and Van der 
Waals interactions of the S conformer. Stacking ability will increase with 
planarity and favorable electronic distribution relative to the stacking 
partner22,23. Electron distribution of aromatic compounds can be altered by 
substituents and cyclic heteroatoms24,25. Whether or not a change in electron 
distribution increases stacking ability depends on the characteristics and 
orientation of the partner in the stacking interaction. As stacking ability of the 
aromatic amine increases within a given sequence context, the conformation 
equilibrium shifts toward the S conformer13,26. 
 
 
Figure 8: (B conformer) Carcinogen is placed in the major groove, Watson-
Crick base pair is maintained. (S conformer) Carcinogen is “stacked” inside 
the duplex and disrupts Watson-Crick base pairing. (W conformer) Minor % 
population, places carcinogen in minor groove. 
 
Properties of the individual carcinogen and neighboring sequence context of 
the duplex are known to affect the ratios of conformational heterogeneity, 
which may have disparate biological outcomes. The two effects are thought to 
be related, but aside from a general trend in stacking ability of the carcinogen, 
little is known about the relationship and their mutational and repair 
outcomes7.  
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2-Aminofluorene (2-AF) is a potent animal carcinogen with the same structure 
as 2-AαC, except 2-AF does not have endocyclic amines at position 1 and 9 
(figure 9). 2-acetylaminofluorene (2-AAF) is identical to 2-AF with the addition 
of an acetyl group on the exocyclic amine. According to the stacking trend one 
would expect to see similar B/S-type ratios between 2-AAF and 2-AF, yet this 
was not observed7,14. A structure activity relationship (SAR) between 2-AF and 
2-AAF reveals an approximate 1:1 B/S conformational heterogeneity in 2-AF, 
while 2-AAF exists mostly in the S- and W-conformation in the same sequence 
context despite their similar ring structure. The difference between these 
conformational population ratios is due to the steric hindrance of the N-acetyl 
group of 2-AAF, restricting rotation around the central nitrogen linking base 
and the carcinogen as well as the glycosidic bond7. 
 
 
Figure 9: Structural comparison of 2-AαC, 2-AF, and 2-AAF. An existing SAR 
of 2-AF and 2-AAF indicate the acetyl group of 2-AAF “locks” the adduct in the 
anti-position of the glycosidic bond. This results in disparate bioactivity. An 
SAR of 2-AαC and 2-AF provide an opportunity to understand the effect of 
disparate electronic configurations in otherwise identical structures. 
 
2-AαC provides a unique opportunity for a SAR when compared to 2-AF. 
Structural and thermodynamic differences will arise exclusively from the 
variations in the electronic configuration of the compounds. In addition to the 
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traditional value structural data on suspected human carcinogens provides, a 
comparison of 2-AαC and 2-AF may help clarify the relationship between 
sequence-dependent and adduct-dependent conformational heterogeneity, 
particularly if this relationship has a dependence on stacking ability. 
 
In principle, thermodynamically favorable stacking positions of aromatic 
heterocycles can be predicted when accounting for the electronic distribution 
of bases and the carcinogen27. This cannot be applied in large systems like 
DNA due to enormous structural and thermodynamic considerations of the 
non-stacking polymeric backbone. However, if sequence context has a 
different impact on adducts that differ only in electronic configuration of the 
carcinogen, this would support the idea that sequence effects may also arise 
because of differences in stacking interactions of the bases. 
 
There is currently no published data regarding the structural or thermodynamic 
properties of 2-AαC DNA adducts. Given its implications in cancer, these 
types of studies are not only warranted, but overdue19,20,28. 
 
Biophysical analyses of normal and modified DNA duplexes yield valuable 
information used in drug development. Depending on the nature of the 
problem being addressed, different analogs of the modifying compound will be 
required. For example, 19F NMR is a powerful tool for assessing the 
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conformational heterogeneity of a modified DNA duplex29,30. To perform this 
type of analysis, a fluorinated analog of the lesion is required31. 
 
The lesion is one of many factors that impact the biophysical properties of 
DNA adducts. When investigating the effect of sequence context on 
biophysical properties, certain methods for adduct synthesis may limit the 
scope of the investigation as will be discussed. There are two major pathways 
for the synthesis of DNA adducts. The first mimics in vivo bioactivation and is 
aptly named biomimetic synthesis (figure 10) and the second is total synthesis 
(figures 11 and 12). 
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Figure 10: Biomimetic synthesis mimics in vivo bioactivation by creating a 
reactive N-hydroxyl electrophile and incorporating effective leaving groups. It 
is then reacted directly with ssDNA. 
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Figure 11: Synthesis of a guanosine phosphoramidite modified by 2-
aminofluorene (2-AF) at the C8 position in preparation for automated total 
oligonucleotide synthesis as reported by Gillet Scharer, 200232. 
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Figure 12: Total synthesis of an oligonucleotide using phosphoramidite 
nucleosides. 
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The biomimetic pathway is quicker and requires fewer synthetic steps than 
total synthesis but restricts the sequence context of the investigation. In 
biomimetic synthesis, the carcinogen is reacted directly with the ssDNA as 
shown previously in figure 10. The electrophile will react with the nucleophillic 
C8 position of guanine. However, if there is more than one nucleophillic site, 
the reaction will be nonspecific and provide a mixture of products (figure 13).  
 
 
Figure 13: Electrophile in biomimetic synthesis reacts at the C8 position of 
guanine. If multiple guanines are present, purification of products is 
combersome. 
 
The total synthetic pathway involves more steps, however the modification is 
incorporated during synthesis of the ssDNA, allowing for any sequence 
context to be investigated. Both pathways have appropriate applications, so 
establishing the viability of both routes would best facilitate a comprehensive 
investigation of 2-AαC-dG adducts in the future. The starting material for each 
route differs by the functional group at the 2-position as shown in figure 14. 
Products	of	Biomimetic	Synthesis: CCCTACGGCTACCC CCCTACGGCTACCC CCCTACGGCTACCC 
CCCTACGGCTACCC 2-N-hydroxy-alpha-carboline ssDNA 
+ N
H
N
NH
OH
G=	Unmodified	Guanine G=	Modified	Guanine 
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Synthesis of starting material for one route can facilitate production of the 
other through established oxidation/ reduction reactions. For example, 2-AαC 
can be oxidized to 2-NαC using dimethyldioxirane, while 2-NαC can likely be 
reduced to 2-AαC using hydrazine or other reducing agents17. 
 
 
Figure 14: Starting material necessary for 2-AαC-dG adducts by route of 
synthesis (biomimetic or total synthetic). Analyses such as 19F NMR require 
specific analogs. 
 
There is great interest in 2-AαC but the lack of efficient synthetic protocols for 
its production is a major issue to research labs. This project will outline a more 
efficient synthesis of 2-AαC as well as necessary analogs for future 
investigations. Additionally, it will describe attempts to improve the versatility 
and ease of the synthesis of C8- (2-AαC)-guanine adducts. 
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2. Synthesis of 2-Amino-α-Carboline and Relevant Analogs 
 
Synthetic strategies yielding carboline analogs, including 2-AαC, have existed 
in literature for decades33,34. However, these syntheses are inefficient and low 
yielding. Over the last decade the fluorescent, medicinal, and carcinogenic 
properties of these compounds have generated interest in carboline 
research35–37. As a result, the development of more efficient synthetic routes 
have presented in literature37–39. 
 
Given the wide range of interesting properties carbolines present, highly 
specific analogs containing functionalities necessary to investigate the 
characteristics of 2-AαC lesions may easily have been overlooked. New 
synthetic strategies for indole-like compounds often consist of a Pd-catalyzed 
cross coupling reaction followed by a Pd-catalyzed intramolecular cyclization, 
or a Cadagan reductive cyclization37–42.  
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Figure 15: Recent synthesis of carbolines. (A) Suzuki coupling followed by a 
Pd-Catalyzed intramolecular coupling with incorporation of an amine. (B) 
Intramolecular cross-coupling. 
 
A major goal of modern organic chemistry is to streamline chemical synthesis 
and maximize the utility of new reactions. Therefore, when a new strategy is 
reported, it is often accompanied by several examples with many 
functionalities and conditions to demonstrate robustness.  
 
Examples of synthetic strategies for carbolines containing the individual 
functional groups necessary for this project are present in literature but their 
combination and position present complications. Furthermore, modern 
syntheses of alpha carbolines with common functionalities often require 
complex conditions that are not particularly robust compared to other indole-
like compounds37,38,40. 
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Early carboline syntheses took advantage of the cyclization reactions of 
triazoles and azaindoles43–45. These reactions often occur under simple 
conditions and are compatible with primary amines but those reported thus far 
require several steps and exhibit low yields.  
 
 
Figure 16: Abbreviated scheme for 2-AαC synthesis by Matsumoto et al.,1979 
utilizes cyclization of triazole34. 
 
New higher yielding synthetic strategies have complex conditions and high 
sensitivity to the presence of amines38,39,41,42. In the scope of this project, low 
yields are acceptable, but simplifying conditions and minimizing the number of 
steps is highly desirable. For this project, two routes for the synthesis of 2-AαC 
were investigated simultaneously.  
 
The first proposed route seeks to take advantage of high yielding cross-
coupling reactions to obtain 2-AαC in two steps from commercially available 
starting material (figure 17). The second proposed route utilizes the Graebe-
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Ullman cyclization of triazole, the final step of an existing synthesis for 2-AαC34 
(figure 30). The latter is based on a reasonable assumption that the 2-AαC 
precursor in the reported synthesis can be obtained from commercially 
available starting material using a number of coupling strategies that have 
been developed since the initial report, thus reducing the total number of steps 
from five to two. 
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2.1 Suzuki Coupling Followed by Reductive Cyclization 
 
A thorough literature search was performed in order to determine which cross-
coupling and cyclization reactions to utilize. Factors taken into consideration 
include functional group compatibility and availability of proposed starting 
material. Primary amines that are not part of the desired reaction often retard 
cross coupling via coordination with the metal catalyst, and/or through the 
production of by-products. This problem is often mitigated by the protection 
and de-protection of primary amines before and after cross coupling steps. 
Cross-coupling reactions that have demonstrated compatibility with 
unprotected primary amines were given preference in the interest of 
minimizing the total number of steps to maximize ease and accessibility of the 
product. 
 
Following the cross coupling step, an intramolecular coupling or cyclization 
can be used to generate the carboline skeleton. This has been reported using 
intramolecular arylation, amination, and photo stimulated cyclization37,39,41. 
These methods require complex reaction conditions and exhibit limited 
compatibility with desired functional groups, particularly primary amines. For 
this reason, these methods were not considered for the initial investigation but 
remain a possibility for the production of 2-AαC. 
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The Cadagan Reductive Cyclization has been used with great success in the 
production of carbazoles, and has had some utility in carboline 
synthesis38,40,41. Reaction conditions range from simple to complex. 
Importantly, the presence of heteroatoms has a less dramatic impact on the 
outcome compared to the previously mentioned reactions. Furthermore, there 
is precedent in literature describing use of the Cadagan Reductive Cyclization 
with unprotected primary amines. 
 
Figure 18: Proposed scheme. Suzuki coupling followed by a reductive 
cyclization may produce 2-AαC (1-4a) in 2-steps. 
 
Consistent with the previous discussion, the proposed 2-step reaction for the 
synthesis of 2-AαC (1-4a) consists of a Suzuki Coupling followed by a 
Cadagan Reductive Cyclization (figure 18)40,46. When performing a retro-
synthesis of the proposed scheme, several possibilities for starting material 
are available (figure 19). However, the decision was limited by the immediate 
commercial availability of the proposed structures. 
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Figure 19: Retrosynthesis of Suzuki coupling/ Cadogan reductive cyclization 
reveals several combinations of possible starting material. Limitations are 
based on immediate commercial availability and cost. 
 
The commercial availability of possible starting material causes a notable 
concern during reductive cyclization. Placement of the nitro group on the 
phenyl ring rather than the pyridine raises the possibility of two carboline 
products as a result of the freedom of rotation around the bond connecting the 
two rings. The possible products are the desired 2-AαC (1-4a), and an 
undesired 2-AγC (1-6) assuming no side reactions (figure 20). 
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Figure 20: Free rotation around single bond on product of suzuki coupling 
using starting material from figure 19 may result in 2 final products: 2-AαC (1-
4a) and 2-AγC (1-6). 
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2.1.1 Early Attempts: 
 
  
Figure 21: Step 1, Suzuki Coupling. 
The coupling of 2-amino-5-bromopyridine (1-1) with phenylboronic acid (1-7) in 
ethylene glycol without the use of ligands or protecting groups has been 
reported46. This system was used as a control to investigate initial conditions 
for the proposed reaction (figure 22). 
 
 
Figure 22: Coupling of 2-amino-5-brompyridine (1-1) and phenylboronic acid 
(1-7) as reported by González et al., 2005 was used as a control. 
 
The report cites coordination between the primary amine and the bidentate 
ethylene glycol as a possible explanation for primary amine compatibility. The 
control reaction was performed simultaneously with the experimental reaction 
of 2-amino-5-bromopyridine (1-1) and 2-nitrophenylboronic acid (1-2a) under 
the reported conditions. Traditional Suzuki Coupling solvents were also used 
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for good measure. As expected, the control reaction was successful in 
producing 1-8, but 1-3a was not produced in the desired reaction. 
 
The presence of a 2-nitro group on the 2-nitrophenylboronic acid (1-2a) is the 
only deviation from the control conditions in the experimental reaction. This 
indicates the nitro group of 2-nitrophenylboronic acid (1-2a) is causing 
undesired results. The root cause can be a function of several properties of 
the 2-nitro group. For example, steric hindrance caused by the position of a 2-
nitro moiety may physically hinder transmetallation. The strong electron 
withdrawing properties of nitro groups may also inhibit this step. Furthermore, 
coordination of the nitro functionality with the catalyst may hinder the formation 
of an appropriate Pd-complex47. 
 
However, when using 2-nitrophenylboronic acid (1-2a) under the control 
conditions, 1H NMR and MS results reveal nitrobenzene as a major product, 
suggesting that deboronation of the starting material is occurring (figure 23).  
 
 
Figure 23: Deboronation of 1-2a during the desired Suzuki coupling. 
 
Where ethanol and Na2CO3 are used as the solvent and base respectively, 
only 2-amino-5-bromopyridine (1-1) and nitrobenzene (1-9) are present after 
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work-up. Where the base is K3PO4 or K2CO3 and the solvent is propylene 
glycol or ethylene glycol, two additional products are present. One of those 
products is possibly the result of homocoupling between 2-amino-5-
bromopyridine (1-1) as suggested by the 1H NMR spectrum. 
 
 
Figure 24: (A) Symmetry and peak splitting observed in 1H NMR in MeOD are 
consistent with product of homocoupling (1-10) but not confirmed. (B) 1H NMR 
of recovered 2-amino-5-bromopyridine (1-1) 
 
If the rate of deboronation is faster than the rate of the catalytic cycle up to 
transmetallation, formation of the desired product will only occur in low yields, 
if at all. Deboronation, combined with the previously mentioned consideration 
of steric hindrance from the 2-nitro group further convolutes the probability of 
product formation via this route. 
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Figure 25 shows the effect temperature and Pd(OAc)2 have on the 
deboronation of 2-nitrophenylboronic acid (1-2a) under Suzuki coupling 
conditions48. While the reported solvent and base differ from the control 
reaction, the results indicate that for the proposed reaction to work, 
deboronation will need to be managed by altering certain conditions48. 
 
 
Figure 25: Table and data from Gonzalez et al., 2005 showing the effect of 
temperature and Pd(OAc)2 on deboronation48 
 
  
I B(OH)2
NO2 NO2
H2O
CH3OH
K2CO3
Cat.
Conv.	Ph-I Yield Cat. T	[oC] t Pd(OAc)2 20 70 100 15	min 15	min 30	min 0% 0% 0% 0% 31% 84% 
- 70 100 150 15	min 30	min 24	h 0% 0% 0% 12% 19% 22% 
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2.1.2 Troubleshooting 
 
An investigation was performed in order to determine what parameters can be 
changed in the control reaction while still undergoing the desired coupling. 
Given the lack of by-products in the control reaction (figure 22), the crude 
product could be assessed by 1H NMR after work-up without further 
purification. Complete disappearance of the 2-amino-5-bromopyridine (1-1) 
starting material indicates 100% product formation on the relative scale used 
in this analysis and does not represent yield. The 6-H pyridine peaks for the 
starting material (1-1) and product (1-3a) in the crude product mixture were 
integrated and the ratios used to determine relative completion of the reaction 
for each parameter investigated.  
 
To investigate the effect of temperature on the control reaction, the reaction 
was ran at a range of temperatures, and analyzed via 1H NMR. The ratio of 
the 6-H pyridine singlet in the product (1-3a) was compared to the 6-H pyridine 
singlet in the starting material (1-1) and used to approximate completion of the 
reaction under the given conditions as shown in figures 26, and 27. As 
expected, the effect of temperature on the control reaction favored higher 
temperatures up to 80o C (higher temperatures were not tested in ethylene 
glycol). 
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Figure 26: 1H NMR of crude product in MeOD produced from Suzuki coupling 
at a range of temperatures. The relative percent ratio of the 6-H pyridine peaks 
at δ 7.95 (1-1) and δ 8.2 (1-8) were used to determine completion of reaction. 
 
 
Figure 27: Relative percent ratio of product and starting material present after 
reaction at different temperatures. Percents were determined from the 1H 
NMR  ratio described in figure 26. 
 
In addition to temperature, alternative Pd-catalysts, bases, and solvent 
systems were investigated. Results for Pd-catalysts are shown in figure 28. 
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Catalysts have different oxidation states and ligand groups. The most effective 
catalysts were Pd(OAc)2 and PdCl3, but all catalysts used produced the 
intended product (1-8). Selected results for other parameters investigated in 
the control reaction are shown in figure 29.  
 
 
Figure 28: 1H NMR of crude product in MeOD was used as described 
previously to determine the percent ratio of starting material (1-1) to product 
(1-8) in the reaction mixture for different catalysts. 
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Figure 29: 1H NMR of crude product in MeOD was used as described 
previously to determine the percent ratio of starting material (1-1) to product 
(1-8) in the reaction mixture for different variables. When NaHCO3 is the base, 
the reaction does not progress to completion. Not all variables tested are 
shown. 
 
Due to the success of a simultaneous investigation, time invested in the 
Suzuki Coupling/Cadagan Reductive Cyclization strategy was reduced and 
eventually eliminated. 
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2.2 Cu-Catalyzed Buchwald/Hartwig Coupling Followed by Graebe-Ullmann 
Cyclization of Triazole. 
 
Synthesis of 2-AαC has been achieved using various strategies. Each 
reported route consists of many steps, often several that require 
chromatographic purification, resulting in low overall yields and high costs. Of 
particular interest was the 5-step reaction reported by Matsumoto et. al., 
197934. The precursor of the final product resembles a possible Buchwald-
Hartwig Cu-Catalyzed coupling product of benzotriazole (2-2a) and 2-amino-6-
bromopyridine (2-3) (figure 30)49. Synthesis of the precursor in a single step 
from commercially available starting material opens the possibility of producing 
2-AαC (1-4a) in only 2 steps. 
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Figure 30: Comparison of previoulsly existing scheme (red) vs proposed (blue) 
scheme. (A) Scheme by Matsumoto et al., 1978 requires 5 steps to produce 2-
AαC. (B) Step 1 of the proposed route, a Cu-catalyzed Buchwald-Hartwig 
coupling, produces the immediate precursor of 2-AαC from Matsumoto et al., 
1978, reducing the overall scheme from 5 to 2 steps34,49. 
 
In the proposed scheme, commercially available starting material can account 
for all analogs necessary for dG-2-AαC adduct synthesis and 19F NMR 
analysis via the proposed route as seen in figure 31. 
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Figure 31: Production of 2-AαC (1-4a), 2-NαC (1-5a), and fluorinated analogs. 
(a) NaNO2, AcOH, H2O, RT, 20-30 min. (b) H2SO4, H2O2, H2O, RT, 24-48 h. 
(c) CuI (5 mol%), K3PO4, N,N’-dimethylethylenediamine (DMEDA), DMF, 
110oC, 24-48 h. (d) Polyphosphoric acid (PPA), 180oC, 30 min.  
 
There are possible concerns regarding synthesis of the fluorinated analogs by 
this route due to the possibility of tautomerization of the 6-fluorobenzotriazole 
(2-2b). This will be discussed in detail later (figure 46). For now, it is not of 
great concern because 19F NMR experiments can be performed with fluorine 
in the 7 or 6 position. 
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2.2.1 Step 1: Cu-Catalyzed Coupling of Nitro Stating Material to Produce 6-
(1H-benzotriazol-1-yl)-2-nitropyridine (2-5a) 
 
 
Figure 32: (a) Step 1, CuI (5 mol%), K3PO4, DMEDA, DMF, 110o C, 24hrs. 
An oven-dried 50 mL round bottom flask with a small stir-bar was charged with 
300 mg of benzotriazole (2.51 mmol), 614 mg of 2-bromo-6-nitropyridine (3.01 
mmol), 24 mg CuI (0.13 mmol, 5 mol%), and 1.11g K3PO4 (5.27 mmol). The 
round bottom was sealed using a rubber septum, air was removed using a 
vacuum, replaced with N2, and repeated three times. An N2 balloon connected 
to a syringe was left in the septum. 27 µL of N,N’-dimethylethylenediamine (22 
mg, 0.25 mmol) and 2 mL of DMF were mixed, taken up into an airtight 
syringe, and injected into the reaction flask. The round bottom was placed into 
an oil bath at 90o C and stirred for 24 hours.  
 
The crude product results in 2 major spots and 1 minor spot on an aluminum-
backed silica TLC plate with an absorbance indicator at 254 nm. The least 
polar spot represents the product with an Rf value of 0.63 in a mobile phase of 
20% EtOAc in hexane. The crude product was purified by column 
chromatography in a glass column using silica stationary phase and a step-
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wise gradient of the EtOAc/hexane mobile phase. The gradient started at 0% 
EtOAc and increased in increments of 5% ethyl acetate until each spot eluted. 
The progress of the separation was monitored by TLC (figure 33). After 
confirming the presence of the desired product, a Medium Pressure Liquid 
Chromatography (MPLC) method was developed on CombiFlash to better 
facilitate scaling up (figure 33). 
 
 
Figure 33: (A) TLC 20% EtOAc/hexane, product Rf = 0.63. (B) Normal phase 
MPLC chromatogram for reaction c. Gradient (percent EtOAc in hexane) = 
blue line. Red line = absorption at 260 nm. Purple line = absorption at 260 nm. 
The desired product (2-5a) is the major peak and elutes from 9-10 min. 
 
The eluent containing the spot with Rf 0.63 was evaporated leaving behind 
280 mg of a yellow crystalline solid. A portion of the solid was dissolved in 
DMSO-d6 and analyzed by 1H NMR revealing a spectrum consistent with the 
desired product (Figure 34).  
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Figure 34: 1H NMR in DMSO-d6 for 6-(1H-benzotriazol-1-yl)-2-nitropyridine (2-
5a) after column chromatography.  
 
The spin systems are consistent with the 2-AαC precursor in figure 30, but in 
this case there is a nitro group in place of the amine. The triazole cyclization to 
produce the carboline product has not been reported with the nitro compound. 
Given the simplicity of the reaction, the fastest way to investigate compatibility 
is to attempt the desired reaction. 
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2.2.2 Step 2: Triazole Cyclization to produce 2-nitro-9H-pyrido[2,3-b]indole, (2-
nitro-α-carboline, 2-NαC, 2-6a) 
 
 
 
Figure 35: (d) Step 2, Polyphosphoric acid (PPA), 30 minutes, 180o C 
A 50 mL round bottom flask was charged with 50 mg of product (1) from figure 
31. Approximately 700 mg of polyphosphoric acid (PPA) was transferred to the 
round-bottom using a glass stir rod. The flask was transferred to an oil bath 
that was pre-heated to 180o C. After 10 minutes, the PPA turned a light brown/ 
caramel color. Small bubbles can be observed, presumably from the release 
of N2. After approximately 30 minutes, bubbles are no longer visible in the 
PPA. If there is SM stuck to the sides of the flask, it can be rotated and 
dissolved in PPA at which point small bubbles can again be observed until the 
reaction is complete (this can be performed as soon as the PPA is viscous 
enough to move around the flask; there is no need to wait until completion). 
The flask is then cooled at room temperature and diluted with water. For the 
purpose of solubility, it is best to dilute with water before the PPA reaches 
room temperature. The mixture is then neutralized with NaOH solution to a pH 
of 7 and extracted several times with ether. Evaporating the ether yields 30 mg 
of crude product as a light yellow powder. 
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One major and two minor products are visible by TLC (254 nm). The minor 
products are only visible at high concentrations. The crude product was 
purified by column chromatography in a glass column with a neutral alumina 
stationary phase and an isocratic mobile phase of 15% EtOAc/ hexane. The 
separation was monitored by TLC and yielded 22 mg of the major product at 
Rf 0.62. 
 
 
Figure 36: TLC for reaction (d) in 20% EtOAc/hexane. Desired product (2-5a) 
Rf = 0.62. Lane 1 & 3 = crude product from reaction (d), lane 2 = 2-5a after 
column chromatography. 
 
The major product was dissolved in DMSO-d6 and analyzed by 1H NMR. 1-D 
1H NMR showed convincing coupling patterns consistent with the desired 
product. Different NMR solvents were used in order to obtain spectra without 
overlapping peaks to facilitate a more simple interpretation of 2-D NMR data. 
Acetone-d6 is the aprotic solvent of that provides a spectrum without 
overlapping peaks (figures 37-40). 
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Figure 37: 1H NMR for 2-6a in acetone-d6 after chromatographic purification. 
9H proton at δ 11.0, close-up shown for δ 7.15- 8.55. See experimental 
section for 1H NMR spectrum of higher purity in CDCl3. The above sample was 
used to confirm spin systems through COSY 1H NMR. Acetone-d6 was used 
as the solvent due to lack of overlap between peaks.  
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Figure 38: 2D 1H NMR COSY for 2-6a in acetone-d6. Peak 3 & 4 make up 
expected spin system and are assigned based on chemical shift. Proton 
nearest the nitro group (3) will be most deshielded as is observed by the 
chemical shift. 
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Figure 39: 2D 1H NMR COSY 2-6a in acetone-d6. Triplets of 6/7 and doublets 
of 5/8 make up the expected spin system. Individual assignment cannot be 
made with 1H NMR COSY alone. Heteronuclear correllation would be 
required. 1H NMR COSY does reveal the relative connectivity of the protons to 
each other. 
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Figure 40: 2D 1H NMR COSY of 2-6a in acetone-d6. Triplets 6/7 and doublets 
5/8 make up the expected spin system. Individual assignment cannot be made 
with COSY. Heteronuclear correllation would be required. 
 
The data indicates synthesis of 2-nitro-α-carboline (2-NαC) was successfully 
achieved in two steps. The synthesis of 2-NαC has previously only been 
reported via oxidation of 2-AαC making this the first report directly producing 
2-NαC without the 2-AαC intermediate17,33. 
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2.2.3 Step 1: Cu-Catalyzed Coupling of Amine Starting Material (2-3) to 
Produce 2-amino-9H-pyrido[2,3-b]indole, (2-amino-α-carboline, 2-AαC, 2-7a) 
 
With small-scale production of 2-NαC (1-5a) confirmed, 2-AαC (1-4a) and the 
fluorinated analogs of each need to be produced (1-4b, 1-5b). Given the 
available scheme, 2-AαC can be obtained from the reduction of 2-NαC using 
hydrazine. Reduction of Ar-NO2 with hydrazine is the most common technique 
used for the partial reduction in biomimetic synthesis as described in section 
4.2. If the reaction conditions are not controlled, the nitro group will be fully 
reduced to the amine. Alternatively, 2-amino-6-bromopyridine may be used in 
place of 2-bromo-6-nitropyridine in the established reaction assuming the 
primary amine does not complicate or prevent the Cu-Catalyzed coupling. 
 
 
Figure 41: Step 1, reaction c with amine functionality (2-3). (c) CuI (5 mol%), 
K3PO4, DMEDA, DMF, 110o C, 48 hrs. 
 
Step one was repeated using 100 mg of 2-amino-6-bromopyridine (0.83 mmol) 
and the scaled stoichiometric ratios of the corresponding reagents (figure 31). 
Set-up, work-up, and purification procedures were the same as the nitro 
analog, except where noted. Care was taken to maintain an inert atmosphere 
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during the reaction. After 24 hours, the TLC (254 nm) revealed 3 major spots 
and several minor spots. The least polar spot was the most intense and only 
varied in Rf from the next spot by 0.03 (figure 42). 
 
 
Figure 42: Reconstructed TLC of crude product from reaction c in 40% 
EtOAc/hexane. Desired product, 2-amino-9H-pyrido[2,3-b]indole, (2-amino-α-
carboline, 2-AαC, 2-7a) is spot 1 and represents the major product Rf = 74. 
Spots 2 and 3 represent other major products, remainder of spots are minor 
by-products. Reaction with the amine starting material results in more 
byproducts than the product of the nitro starting material.  
 
During workup, the silica plug was substituted for a neutral alumina plug as a 
precaution for the primary amine. Similarly, a neutral alumina column was 
substituted for a silica column during purification. 
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Isolated spots were analyzed by HNMR in CDCl3. Spot 1 was the most intense 
spot on the TLC plate and corresponded to 2-amino-6-bromopyridine (2-3). 
Spot 2 corresponded to the desired product (2-7a) as seen in figure 43. 
 
 
Figure 43: (A)1H NMR of 2-amino-6-bromopyridine (2-3) in CDCl3 recovered 
after purification of product mixture. (B) 1H NMR of desired product, 2-7a, in 
CDCl3. 
 
The amount of pure product (2-7a) recovered was 11 mg while approximately 
55 mg of 2-amino-6-bromopyridine (2-3) was recovered. This confirms the 
desired product can be formed using this strategy but indicates the reaction 
proceeds more slowly when using the amine starting material (2-3). The 
coupling of 2-amino-6 bromopyridine (2-3) therefore requires a longer reaction 
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time, or a higher temperature. It also has lower yields and more byproducts as 
evident by TLC. 
 
The reaction was repeated and allowed to run for 48 hours. While the spot 
corresponding to the SM was still present, the product spot was now the most 
intense on the TLC and purification yielded 38 mg recovered. In both 
instances, purification was difficult due to the similarity in Rf values of the 
starting material and the product resulting in eluent that contained both spots. 
Originally, this eluent was not further purified and any product it contained was 
not part of the reported recovery making the yield appear lower than reality. 
One of the ways to address this issue during scale-up was to use 2-amino-6-
bromopyridine (2-3) as the limiting reagent. After 48 hours the SM was not 
visible by TLC and 52 mg of the desired product was recovered. 
 
During scale-up an MPLC method was developed for CombiFlash on a neutral 
alumina column. A representative chromatogram is shown in figure 44. 
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Figure 44: MPLC chromatogram from CombiFlash alumina column. 
EtOAC/hexane, EtOAc = solvent B. Dry pack. Amine starting material is 
present in small amount (≈10 min). Product elutes from ≈11-15.5 min. 
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2.2.4 Step 2: Triazole Cyclization to produce 2-amino-9H-pyrido[2,3-b]indole, 
(2-amino-α-carboline, 2-AαC, 1-4a) 
 
 
Figure 45: (d) Step 2, Polyphosphoric acid (PPA), 30 minutes, 180o C 
Since 2-7a is the 2-AαC precursor from figure 30, the next step of the reaction 
is already established. Following the same procedure as reported for 1-5a, 
and that by Matsumoto et al., 2-7a was reacted in PPA as previously 
described. The Turesky group at the University of Minnesota Cancer Center 
provided a reliable 2-AαC standard for analysis. TLC was performed at various 
proportions of EtOAc/ Hexane in comparison with the product and standard. Rf 
values and co-spot tests support production of the desired product.  
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2.2.5 Fluorine Analogs 
 
Having demonstrated the capacity to synthesize both 2-AαC (1-4a) and 2-NαC 
(1-5a) in a two-step reaction, synthesis of the 7-fluorinated analogs (1-4b, 1-
5b) needs to be established for potential 19F NMR experiments. Since there is 
not a known method to selectively fluorinate the 7-position of carbolines, 
fluorine must be present at the start of the reaction as shown in step b of figure 
31. This raises the concern that tautomerization of the 6-fluorobenzotriazole 
during step d will result in an isomeric mixture. If the reaction proceeds there 
are 2 possibilities as described in figure 46. 
 
  
 
Figure 46: Tautomerization of 6-fluorobenzotriazole (2-2b) can result in an 
isomeric mixture. 1-5b and 1-5c represent the isomers. 
 
Since 19F NMR can be performed with the 7-fluoro or 6-fluoro isomer of 1-5 
and 1-4, the only remaining concern is purification, a topic that will be 
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discussed later. A procedure reported by Wasik et al., 2010 was used to 
produce 6-fluorobenzotriazole 2-2b50.  
 
 
Figure 47: Synthesis of 2-2b as reported by Wasik et al., 201050 Note the 
product in their scheme is the undesired tautomer. However, the product 
results in the desired tautomer as measured in NMR solvents on an NMR time 
scale.  
 
Initially 100 mg starting material 2-1 was used, but the reaction was scaled to 
1 g. Because of the nature of their investigation, the authors do not follow the 
conventional heterocyclic numbering format, referring to this product as 5-
fluorobenzotriazole. Tautomerization makes this point relevant upon 
identification of the product’s subsequent coupling with 2-amino-6-
bromopyridine (2-3) and 2-bromo-6-nitropyridine (2-4) as shown in figure 46. 
The production of 6-fluorobenzotriazole (2-2b) was confirmed by 1H NMR in 
DMSO-d6 (figure 48). The spectrum is consistent with the desired product and 
matches that of the reported procedure. 
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Figure 48: 1H NMR (II-F) Acetone D6.  
 
6-fluorobenzotriazole 2-2b was subsequently used in reaction a under the 
same conditions as 2-2a, producing an isomeric mixture. 4 spots are clear on 
the TLC, however the isomeric mixture represents only one of those spots 
unless TLC conditions are optimized (figure 49). 
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Figure 49: TLC (1-F) Least polar spot in (A) represents 2 products as seen 
after 2nd purification in TLC (B).  
 
Initially, the isomeric mixture was isolated as a single spot. The fact that it was 
a mixture became evident after 1H NMR (figure 50).  
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Figure 50: 1H NMR in DMSO-d6 1-5b, 1-5c Isomeric mixture. 
 
Purification of each isomer was done by column chromatography on a glass 
column with a silica stationary phase and very gradual stepwise gradient of 
EtOAc and hexane starting at 0% EtOAc. A larger than average column width 
to height ratio, as well as a larger amount of stationary phase is desirable for 
this purification. Due to similar polarities, purification by column 
chromatography takes several hours. 1H NMR was used to identify the 
isomers shown in figure 51. 
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Figure 51: 1H NMR in CDCl3. Pure isomers as shown in TLC figure 49.  
 
 
Identification of the isomers in figure 51 can be done by performing 1H-15N-
HMBC, or NOESY. However, due to limitations on time, precedent in literature 
(figure 52), and the fact that 19F NMR experiments can be performed with 
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either pure isomer, time was not allocated to increasing the certainty of 
identification. Figure 52 explains how the identity of each isomer was 
determined using meta coupling constants from literature precedent and a 
chemical shift argument. 
 
Figure 52: Justification for 1H NMR assignment of isomers. Reaction reported 
by Liu et al., 2010 does not permit formation of isomeric mixture51. Coupling 
constants of relevant peaks are highlighted and consistent with isomer 
assignments. 
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3. Adduct synthesis 
 
As mentioned previously, the two major pathways for the synthesis of DNA 
adducts are 1) the biomimetic route and 2) the total synthetic route. 
Biomimetic synthesis is a classic approach used to covalently attach bulky 
aromatic electrophiles to the C-8 position of guanine in single-stranded 
oligonucleotides. This strategy mimics the biochemical mechanism of adduct 
formation via reactive N-hydroxyl intermediates (see figures 5 & 10). In vivo, 
amines are partially oxidized to N-hydroxyls by an enzymatic reaction with 
various CYP isoforms (figure 5). During in vitro biomimetic synthesis, amines 
are oxidized to nitro groups, partially reduced to N-hydroxyls, and reacted with 
the nucleophilic sites of DNA as in nature (figure 10). 
 
The biomimetic approach is effective only when there is a single guanine 
present in the oligonucleotide because it can react with any guanine present. 
Therefore an oligonucleotide with just two guanines will produce three 
products via the biomimetic route (figure 13). The problem at this point 
becomes purification of the desired product. Given the size of an 
oligonucleotide, even bulky modifications make purification a cumbersome 
effort. 
 
The total synthetic approach is significantly less restrictive but requires more 
time, equipment, and other resources. In total synthesis, the nucleoside is 
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modified before incorporation into the oligonucleotide typically requiring 
several protecting/ deprotecting steps. After the modification is incorporated, 
the nucleoside needs to be protected for automated solid phase 
oligonucleotide synthesis (figure 12). While this approach may require as 
many as 10-15 steps prior to automation, the reactions are quick, robust, and 
high yielding. Production of the 2-AαC-dG adduct, and its compatibility with the 
conditions of solid phase DNA synthesis are the major concerns of this route. 
 
The total synthetic route provides greater utility for biophysical analysis. 
Therefore, establishing a total synthesis for 2-AαC-dG lesions is important for 
future investigations of this adduct. Furthermore, a biomimetic route has been 
established previously to produce 2-AαC-dG adducts in low yields and small 
scales17,33. Authors have reported difficulties in ease of synthesis, 
reproducibility, and scaling-up. Since biomimetic routes involve fewer steps 
and less resources than total synthesis, it would best facilitate future 
investigations of 2-AαC-dG adducts if both routes were viable, thus biomimetic 
synthesis is included in this project. 
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3.1 Total Synthetic Route 
 
Solid-phase DNA synthesis is currently the most efficient way to synthesize 
natural or modified oligonucleotides of any sequence52. This technique utilizes 
nucleosides with both acid and base sensitive protecting groups in order to 
facilitate selective removal at the appropriate step (Figure 53). As such, 
choosing the appropriate protecting groups during synthesis of the modified 
nucleoside may reduce the total number of steps. 
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Figure 53: Automated DNA synthesis showing essential functional groups and 
their role in solid support polymerization. 
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Nucleoside phosphoramidites have superior yield in automated solid-phase 
DNA synthesis and have become the standard. Unfortunately, the sensitivity of 
phosphoramidites to water and air limit the compatibility of the automation step 
with the conditions necessary for certain nucleoside modifications, thus it is 
not common to see the same protecting groups in the modification step and 
the automation step48,52. This creates additional protecting and deprotecting 
steps to synthesize the modified nucleoside phosphoramidite. Since 
nucleoside phosphoramidites are the standard in DNA synthesis, many 
schemes have been developed to covalently attach various aromatic amines 
at the C8 position of guanosine resulting in desired modified nucleoside 
phosphoramidite.  
  
The most common strategy is to protect the reactive functional groups on the 
nucleoside and use a metal-catalyzed coupling technique to attach the bulky 
modification. The protecting groups are then removed and the new protecting 
groups for DNA synthesis are added. 
 
Pd-catalyzed Buchwald-Hartwig (BH) reactions between the PAH or HAA and 
C8-brominated guanosine are often used for the coupling step32,53. Under 
these conditions, the nucleophilic sites of guanosine must be protected. If 
possible, one would want to use the same protecting groups used in DNA 
synthesis, however, the basic conditions of BH coupling are not compatible52. 
Therefore, different protecting groups must be chosen resulting in lengthy 
 66 
synthetic schemes. Given that these reactions are well established, it is 
reasonable to test the compatibility of this strategy with 2-AαC. 
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3.1.1 Preparing dG for Buchwald-Hartwig Coupling 
 
The scheme reported by Gillet and Scharer, 2002 for C8 modification of dG by 
various aromatic amines was attempted using 2-AαC32. The C8 position of 
guanosine was brominated and the nucleophilic sites were protected following 
the general procedure for coupling PAH’s or HAA’s with guanosine. 2-AF was 
used as a control reaction. 1H NMR in DMSO-d6 was performed on purified 
products and the spectrum compared to that reported by Gillet and Scharer, 
200232. 
 
Step 5 (figure 54) was not compatible with 2-AαC. Figure 55 shows the 1H 
NMR results of the control reaction and matches that of the literature report, 
confirming technique is adequate. Section 4.1.2 discusses troubleshooting 
methods used for 2-AαC. 
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Figure 54: Synthesis of a nucleoside phosphoramidite modified by 2-AF. 1-5 
followed the procedure reported by Gillet and Scharer, 2002 for the 2-AF 
control. Troubleshooting techniques for step 5 using 2-AαC are outlined in 
section 3.1.2. 6-11 are for illustrative purposes only and represent the 
complete scheme reported by Gillet and Scharer, 200232. 
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Figure 55: (A) Purification and (B) Identification by 1H NMR: dG-C8-2-AF 
matches that reported by Gillet and Scharer, 200232. 
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1H	NMR	(DMSO-d6)	(ppm)	8.85	(s,	1H,	N8-H),	7.85	(m,	1H,	AF-C1-H),	7.72-7.77	(m,	2H,	AF-H2),	7.59	(m,	1H,	AF-H),	7.50	(m,	1H,	AF-H),	7.12-7.35	(m,	16H,	AF-H2+Bz-H5+DMTr-H9),	
6.81	(m,	4H,	DMTr-H4),	6.53	(s,	1H,	N2-H),	6.22	(dd,	J=6.7,	6.7,	1H,	C1'-H),	4.88	(br	s,	2H,	Bz-CH2),	4.60	(m,	1H,	C3'-H),	3.76-3.88	(m,	4H,	AF-C9-H2+	C5'-H2),	3.71	(s,	6H,	2"OMe),	3.64	(m,	1H,	C4'-H),	3.42	(m,	1H,	C2'-H),	2.02	(m,	1H,	C2'-H),	0.88	(s,	9H,	tBu-H),	0.80	(s,	9H,	tBu-H),	0.10	(s,	6H,	2"CH3),	-0.03	(s,	3H,	CH3),	-0.05	(s,	3H,	CH3) 
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3.1.2 Troubleshooting the Buchwald-Hartwig Coupling 
 
Coupling of 2-AαC with the protected dG-Br under the reported conditions 
(step 5) was not successful. The success of the 2-AF control reaction under 
identical conditions indicates the problem is specific to the 2-AαC starting 
material. Variables such as solvent, base, co-catalyst ligand, temperature, and 
length of time were systematically changed to see if the reaction of 2-AαC 
would proceed. 
 
 
Figure 56: Buchwald Hartwig catalytic cycle with relevant elements for 
nucleoside synthesis highlighted in red. 
 
Heterocycles often require higher temperatures and longer reaction times 
during BH coupling due to the retarding effect of undesired Pd-coordination 
with non-reacting heteroatoms. Being the simplest variable to change, higher 
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temperatures and longer reaction times were unsuccessfully attempted. As 
expected, this did not have an impact on product formation, however, 
degradation of the protected bromoguanosine was observed after 48 hours. 
 
NatBuO- is a strong base and may result in undesired 9H deprotonation of 2-
AαC. The predicted pKa of 2-AαC in aqueous solution is approximately 14.5 
while the predicted pKa of tBuOH (the conjugate acid of NatBuO-) in aqueous 
solution using the same prediction software is 15.4. Since relative acidity 
determined from pKa values cannot be compared across solvents, this data 
does not provide a definitive conclusion regarding 2-AαC ionization under the 
experimental conditions. 1H NMR of 2-AαC and NatBuO- in toluene with could 
reveal the degree of ionization, however, this experiment was not performed. 
 
 
Figure 57: Possible ionization equilibrium of 2-AαC under Buchwald-Hartwig 
conditions 
 
There are several examples in literature of mildly acidic heterocycles 
successfully undergoing coupling in these conditions, however, it cannot be 
known from the available information if ionization is occurring54. In the 
provided literature examples, 1H NMR experiments were not performed to 
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determine the extent of ionization in the reaction solvent. Furthermore the 
effect of ionization on the catalytic cycle is not well understood. Ionization itself 
may actually have little impact on the catalytic cycle and may be more 
dependent on the overall electronic configuration. 
 
Since the impact of ionization on the catalytic cycle is not well understood, a 
wide range of bases was used, all providing the same negative result. Organic 
bases such as DIPEA and DBU provided low yields of the 2-AF control, and 
did not produce the product when 2-AαC was used. All experimental reactions 
were allowed to run for several days with no product formation observed by 
HPLC. Degradation of the nucleoside SM was observed. 
  
Traditionally, BH coupling of nucleosides is performed in toluene, however, 
other common aprotic solvents were also screened, including THF and 
DMF32,53,55. Changing the solvents had no effect on the outcome. 
  
Arguably, the most important variable that can be altered in a BH system is the 
co-catalyst ligand. The correct choice of ligand is tedious since it is highly 
specific to the starting material, whereas the previous conditions, while easy to 
screen, are general.  
 
BINAP is a ligand that has become standard for Pd-catalyzed coupling of 
nucleosides partly due to its bidentate coordination32,53. This is useful for 
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heterocyclic coupling since heteroatoms are known to interfere with the Pd-
complex and form dimers that disrupt the catalytic cycle (figure 56). The 
affinity of the heteroatom for the Pd complex, and the stability of the dimer are 
important factors in the overall impact dimer formation will have on the 
catalytic cycle. Bidentate ligands are commonly used to sterically hinder 
access to the Pd center and reduce or eliminate dimer formation.54,56 
  
Given the negative results using BINAP as a co-catalyst and the high chemo 
selectivity of ligands for the coupling partner, ligands outside the normal scope 
of BH Pd-catalyzed nucleoside coupling were investigated.  
  
Structural and electronic configurations similar to that of 2-aminopyridine have 
poor success rates in metal catalyzed coupling. This is likely because they 
present an extreme example of undesired heteroatom coordination due to the 
proximity of the heteroatom to the Pd complex. The configuration of 2-AαC 
presents the same challenge. It is interesting to note that heterocycles with 
two nitrogen atoms adjacent to the reacting functional group (either the 
primary amine or the halide) do not have this problem. One could speculate 
that the coordinating strength of these heteroatoms is reduced as a result of 
their competing electronegativity, resulting in an even electronic distribution 
relative to heterocycles with a single heteroatom. 
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Successful coupling of 2-amino-pyridine like compounds has been reported 
with BINAP, XantPhos (bidentate ligands), and tBuXPhos (monodentate 
ligand)54. In each attempt, these ligands were unsuccessful at coupling 2-AαC 
but the control, 2-AF, successfully coupled with its nucleoside partner in 
various yields. 
  
Changes to the solvent, base, co-catalyst ligand, temperature, and length of 
time did not produce the desired product. The structural and electronic 
configuration of 2-AαC is the likely culprit due to various complications it 
presents. As was already discussed, the proximity of the aromatic heteroatom 
relative to the reactive amine results in an increased possibility of undesired 
Pd-coordination. This essentially causes it to act as a bidentate ligand with 
high affinity for the Pd complex.  
 
Furthermore, the electronic properties that result from the secondary amine in 
the 9-position and a tertiary aromatic amine in the 2-position raises the 
possibility of tautomerization that would be unfavorable for BH conditions. The 
BH ligands that have been tested thus far are used for coupling primary 
amines, whereas the tautomer is a secondary amine. While the HNMR for 2-
AαC does not indicate the presence of the tautomer in question, one cannot 
be certain the reaction conditions do not alter the thermodynamic stability of 
the tautomer. 
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Figure 58: Possible tautomerization of 2-AαC. Secondary amine formation is 
unfavorable for the BH conditions being utilized. 
  
As was already discussed, deprotonation/ ionization at the 9H position may be 
responsible for difficulty coupling 2-AαC (figure 57). This is a less likely cause 
relative to the effects of the electronic and structural configuration because of 
the range of bases that were tested, and the numerous coupling examples in 
literature that use starting material with similar acidity to 2-AαC. There is no 
doubt the problem arises from properties of the secondary amine in the 9-
position since the otherwise structurally identical 2-AF is capable of coupling 
with the nucleoside under many of the conditions that were explored. 
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3.1.3 Alternative Plans 
  
There are many reasonable strategies to further troubleshoot this reaction and 
total synthesis. Given time constraints and uncertainties associated with 
further investigating this reaction, we turned our attention to the biomimetic 
synthesis. Below are alternative plans that were discussed in order to achieve 
total synthesis if time were to be allocated. 
  
A protecting group may reduce or eliminate effects the 9H proton has on the 
catalytic cycle. As was already discussed, deprotonation/ ionization itself is not 
likely a major concern. However, a protecting group could have several 
effects. First off, the deprotonation at the 9H position increases the possibility 
of unfavorable 2-AαC tautomers. Furthermore, a bulky protecting group in the 
9-position may sterically hinder the 1-position and reduce coordination of the 
aromatic amine with the Pd complex. Using a bulky protecting group could 
potentially address several concerns at once. The downside of this approach 
is the addition of a protecting and deprotecting step to an already lengthy 
protocol. Ideally, the protecting group could be removed during the same step 
as another protecting group on the nucleoside. 
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3.2 Biomimetic Synthesis 
 
It has been shown in vitro and in vivo that 2aAc is metabolized by CYP 
isoforms to the N-hydroxyl, converting the amine into a reactive electrophilic 
intermediate that reacts with the nucleophilic C8 position of guanine17,18,21. 
Additionally, it undergoes UGT N-glucorination in the liver and is more reactive 
towards the C8 position of guanine than the N-hydroxy intermediate. This 
biological process can be mimicked to yield the desired C8-2aAc guanine 
oligonucleotide. 
 
Biomimetic synthesis has been used for decades17,33. It takes advantage of 
the reactivity of metabolites like the N-hydroxyl intermediate. Similar to the 
UGT N-glucorination, bulky leaving groups can be added that will increase 
reactivity and selectivity of the N-hydroxyl. Over time, these leaving groups 
have been established resulting in successful strategies for biomimetic 
synthesis summarized in figure 10. Path 2 is the highest yielding and most 
efficient option for aromatic amines.  
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3.2.1 Control reaction with 2-fluoro-6-nitro-fluorene 
 
A 100 ml round bottom flask was charged with 300 mg of 2-fluoro-6-nitro-
fluorene and a stir bar. The solid was dissolved in 10 mL THF and allowed to 
stir on ice. To the solution, 200 mg of 5% Pd/C were added. At 0o C, hydrazine 
was added in 50 µL increments every 15-20 minutes. After each addition, 100 
µL of the solution was removed and diluted to 1 mL with MeOH and 
centrifuged for 2 minutes. The sample was analyzed by HPLC on a 
photodiode array. The reaction was stopped after approximately a 90% 
reduction in the UV signal of the nitro starting material. 
 
 
Figure 59: HPLC chromatogram, 70% MeOH in H2O, isocratic. (A) Partial 
reduction of 2-FAF to N-hydroxyl-2-fluroflourene. (B) Comparison of confirmed 
UV spectra indicate success of the control reaction. 
A 
B 
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The UV spectra matched previous runs that had been confirmed in the Cho 
lab (figure 59). Following the established procedure, the N-hydroxyl product 
was used in the next step of biomimetic synthesis. Figure 60 shows PDA 
results for each step of the reaction with a comparison to previously confirmed 
spectra. 
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Figure 60: Biomimetic control reaction. Scheme from figure 10, route 2 was 
executes for 2-AF. PDA UV spectrum was compared to confirmed spectra. 
According to this data all 2-AF control reactions were successful. Due to the 
established protocols and UV spectra in the Cho lab, this was the only means 
of identification. 
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3.2.2 Results Using 2-AαC 
 
Figure 61: Partial reduction of 2-AαC under identical conditions to the control 
2-FAF. 
 
Having demonstrated proper technique for the partial reduction, attempts were 
made using 2-NαC. The established conditions for 2-fluoro-6-nitro-fluorene 
were not compatible with 2-NαC as shown by the representative HPLC 
chromatogram in figure 62. 
 
Figure 62: Chromatogram from partial reduction of 2-AαC. No product 
formation. Time point 0, before addition of hydrazine. Time point (1-4) 15 
minute intervals. Time point 5 +2 hours, time point 6, +24 hours at RT. Excess 
hydrazine added. 
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Novak et al. reported the partial reduction of 2-AαC and noted sensitivity to air, 
moisture, and peroxides that are not as pervasive in the fluorene model33. The 
conditions were modified to accommodate more sensitive reagents.  
 
 
Figure 63: Adjustments made based on Novak’s model. Explanations in text. 
 
Fresh, commercially available, anhydrous THF was degassed and treated with 
heat-activated 4Å molecular sieves under N2 for 2.5 hours (figure 63 B). An 
ethylene glycol/EtOH bath was used in combination with dry ice to manipulate 
the temperature from -20o C to 0o C during the reaction (figure 63 C). 2-NαC 
was added to a 25 mL pear bottom and fitted with an adaptor and septum as 
shown in figure 63 D. The system was vacuumed and backfilled with N2 three 
times. THF was added through a syringe and 2-NαC was dissolved. The pear 
bottom was placed in the ethylene glycol/EtOH dry ice bath and the 
temperature was monitored to -20o C. The septum was removed under a 
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steady stream of N2, 5% Pd/C was added to the flask, and the septum was 
immediately replaced. Hydrazine was added as a mixture with THF, and a 
sample was removed for HPLC analysis by a glass syringe with an 8-inch 
needle. After 5 hours no change occurred. 
 
Despite the structural similarities of 2-AF and 2-AαC, 2-fluoro-6-nitro-fluorene 
undergoes the partial reduction and subsequent biomimetic reactions, 
whereas 2-NαC does not. The endocyclic amines of 2-NαC drastically alter the 
electronic configuration within the structure compared to 2-fluoro-6-nitro-
fluorene and can effect redox reactions. Ionization of the 9H proton and 
tautomerization of 2-NαC are also potential obstacles for the reduction in 
hydrazine. Coordination with Pd/C is also a possibility given the position of the 
1-N relative to the 2-NO2 site being reduced to the N-hydroxyl.
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4. Experimental 
 
In Section 2, new compounds were created, and shorter routes to synthesize 
old compounds were established. Figure 31 outlines the synthetic plan and 
provides an overview of the scheme. Execution of the plan was described in 
the text, however, figure 64 summarizes what compounds were successfully 
synthesized and what compounds are new. This section will provide further 
experimental details on compounds that are new or were synthesized using a 
new strategy. 
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Figure 64: Compounds synthesized in the triazole route. New compounds are 
indicated as such. (a, b) First report for synthesis of 2-7a and 1-4a via 
proposed route. . (c) First known report of 1-5a not via oxidation of 1-4a. 
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6-(1H-benzotriazol-1-yl)-2-nitropyridine 
 
 
 
Figure 65: (2-5a) 
 
An oven-dried 50 mL round bottom flask with a small stir-bar was charged with 
300 mg of benzotriazole (2.51 mmol), 614 mg of 2-bromo-6-nitropyridine (3.01 
mmol), 24 mg CuI (0.13 mmol, 5 mol%), and 1.11g K3PO4 (5.27 mmol). The 
round bottom was sealed using a rubber septum. Air was removed using a 
vacuum syringe and replaced with N2 (repeated three times). A balloon filled 
with N2 connected to a syringe was left in the septum. 27 µL of N,N’-
dimethylethylenediamine (22 mg, 0.25 mmol) and 2 mL of DMF were mixed in 
a small Erlenmeyer flask, taken up into an airtight syringe, and injected into 
the reaction flask. The round bottom was placed in a pre-heated oil bath at 
90oC and stirred for 24 hours. 
 
Rf 0.63 in 20% EtOAc/hexane. The crude product was purified by column 
chromatography on a silica stationary phase and a step-wise gradient of 
EtOAc/hexane. The gradient started at 0% EtOAc and increased in increments 
of 5% EtOAc until each spot eluted. Separation was monitored by TLC (figure 
33). The mobile phase containing the purified product was evaporated and the 
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product transferred to an oven-dried 50 mL round bottom flask. Approximately 
3-5 mg was taken for NMR and the round bottom was wrapped in aluminum 
foil (light protection) and left on a vacuum for 4 hours. 280 mg (1.16 mmol) of 
2-5a was recovered, providing a 46% yield. 
 
1H NMR and 13C NMR in CDCl3 are consistent with desired product. To fully 
characterize this compound, MS is needed. 
 
 
Figure 66: 1H NMR in CDCl3 δ (ppm), J (Hz) 8.61 (1H, d, J= 8.71), 8.29 (1H, d, 
J= 9.24), 8.13 (1H, d, J= 8.19), 7.79 (1H, t, J= 7.91), 7.66 (1H, td, J= 8.21, 
1.14), 7.51 (1H, d, J= 7.91), 7.49 (1H, td, J= 8.15, 0.90). Ethyl Acetate (EtOAc) 
impurity, NMR solvent (CHCl3), and TMS are identified in the spectrum.  
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Figure 67: 13C NMR in CDCl3 δ (ppm) 151.08 (1C), 146.73 (1C), 140.82 (1C), 
139.98 (1C), 131.27 (1C), 129.28 (1C), 126.20 (1C), 125.22 (1C), 119.74 (1C), 
114.66 (1C), 112.42 (1C). Ethyl Acetate (EtOAc) impurity, NMR solvent 
(CHCl3), and TMS are identified in the spectrum. 
 
A Medium Pressure Liquid Chromatography (MPLC) method was developed 
on CombiFlash to better facilitate scaling up (figure 33). 
 
 
Figure 68: Normal phase MPLC chromatogram for reaction c. Gradient is 
EtOAc (%B) in hexane shown as a blue line. Red line = absorption at 260 nm. 
Purple line = absorption at 260 nm. The desired product (2-5a) is the major 
peak and elutes from 9-10 min 
EtOAc EtOAc 
EtOAc TMS 
CHCl3 A 
B 
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2-nitro-9H-pyrido[2,3-b]indole, (2-nitro-α-carboline, 2-NαC) 
 
 
Figure 69: 1-5a 
 
To the 50 mL round bottom flask containing 50 mg (0.207 mmol) of 2-(1H-
benzotriazol-1-yl)-6-nitropyridine (2-5a) was added 700 mg of Polyphosphoric 
acid (PPA) using a glass stir rod. The round bottom flask was placed in a 
preheated oil bath at 180oC. The reaction mixture turns from 
transparent/colorless to light brown. Bubbles can be observed until the 
reaction is complete (approximately 30 minutes). If starting material is stuck to 
the sides of the round bottom flask, the flask can be rotated so the solid is 
dissolved in PPA. Bubbles can again be observed until the reaction is 
complete (this can be performed as soon as the PPA is viscous enough to 
move around the flask; there is no need to wait until completion). 
 
The crude mixture was cooled at room temperature, diluted with water, and 
neutralized to pH 7 with 1M NaOH. For the purpose of solubility, water was 
added before the PPA reached room temperature. Product was extracted with 
ether several times until aqueous layer did not show absorbance on TLC 
plates with 254nm indicator. Rf = 0.62 in 20% EtOAc/Hexane on silica TLC 
plates. The crude product was purified by column chromatography in a glass 
N
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column with a neutral alumina stationary phase and an isocratic mobile phase 
of 15% EtOAc/ hexane. 22 mg (0.103 mmol) of product (1-5a) was recovered 
providing a 49.8% yield. 
 
1H NMR in Acetone-d6 is consistent with desired product. To fully characterize 
this compound, MS and 13C NMR are needed. 
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Figure 70: 1H NMR in Acetone-d6 δ (ppm), J (Hz) 8.42 (1H, d, J= 8.01), 8.17 
(1H, d, J= 7.74), 7.60 (1H, d, J= 8.01), 7.51 (1H, td, J= 7.48, 1.21), 7.39 (1H, 
d, J= 8.01), 7.29 (1H, td, J=7.74, 1.06). Ethyl Acetate (EtOAc) impurity, NMR 
solvent (Acetone-d6), vacuum grease, and TMS are identified in the spectrum. 
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Figure 71: 2-7a 
 
The same procedure was followed as for 2-(1H-benzotriazol-1-yl)-6-
nitropyridine using appropriately scaled stoichiometric ratios except the 
reaction is ran for 48 hours due to the retarding effect the primary amine has 
on Cu coordination. The similarity in Rf values between 2-amino-6-
bromopyridine and the desired product, 6-(1H-benzotriazol-1-yl)-2-
aminopyridine, can make purification tedious. Changing 2-amino-6-
bromopyridine to the limiting reagent (previously benzotriazole) simplifies 
purification. Coupling of 2-amino-6-bromopyridine (2-3) resulted in moderate 
yields (20%) compared to the nitro starting material (2-4), presumably due to 
complications caused by the primary amine. 
 
1H NMR in CDCl3 is consistent with the desired product. To fully characterize 
this compound, MS and 13C NMR are needed. 
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Figure 72 1H NMR in CDCl3 δ (ppm), J (Hz) 8.57 (1H, d, J= 8.31), 8.11 (1H, d, 
J= 8.31), 7.66 (1H, t, J= 7.90), 7.58 (1H, d), 7.56 (1H, td, J= 8.75, 1.33), 7.42 
(1H, td, J=7.40, 0.90) 6.52 (1H, d, J= 7.90), 4.67 (2H, s). NMR solvent 
(CDCl3), vacuum grease, and TMS are identified in the spectrum. 
 
 
An MPLC method was developed for CombiFlash on a neutral alumina column 
to facilitate scaling up. A representative chromatogram is shown in figure 44. 
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Figure 73: Normal phase MPLC chromatogram for reaction c to produce 2-7a. 
Gradient is EtOAc (%B) in hexane shown as a blue line. Red line = absorption 
at 260 nm. Purple line = absorption at 260 nm. The desired product (2-7a) is 
the major peak and elutes from 12-16 min. 
 
 
2-amino-9H-pyrido[2,3-b]indole, (2-amino-α-carboline, 2-AαC) 
 
 
Figure 74: (1-4a) 
 
The same procedure was followed as for 2-nitro-9H-pyrido[2,3-b]indole, (2-
nitro-α-carboline, 2-NαC) using appropriately scaled ratios. The Turesky group 
at the University of Minnesota Cancer Center provided a reliable 2-AαC 
standard for analysis. TLC was performed at various proportions of EtOAc/ 
Hexane in comparison with the product and standard. Rf values and co-spot 
tests support production of the desired product. Cyclization of 2-7a resulted in 
N
H
N NH2
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moderate yields (15%) compared to the nitro starting material (2-5a), 
presumably due to complications caused by the primary amine. 
 
6-(5-fluoro-1H-benzotriazol-1-yl)-2-nitropyridine 
 
 
Figure 75: (2-5c) 
 
The same procedure was followed as for 2-(1H-benzotriazol-1-yl)-6-
nitropyridine using appropriately scaled stoichiometric ratios. Benzotriazole 
was replaced by 6-fluorobenzotriazole. The reaction produced an isomeric 
mixture of 6-(5-fluoro-1H-benzotriazol-1-yl)-2-aminopyridine and 6-(6-fluoro-
1H-benzotriazol-1-yl)-2-aminopyridine. The isomers purified by column 
chromatography on silica gel in a stepwise gradient of EtOAc/Hexane starting 
at 0% EtOAc increasing in 5% increments. Separation was monitored by TLC. 
1H NMR was initially performed in DMSO-d6. To fully characterize this 
compound, MS and 13C NMR are needed. Yield was not recorded for the 
fluorinated analogs. 
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Figure 76: 1H NMR in DMSO-d6 δ (ppm) 8.34 (1H, m), 8.29 (1H, d), 8.15 (1H, 
dd), 8.10 (1H, t), 7.81 (1H, d), 7.51 (1H, dt). Coupling constants are measured 
in CDCl3 and explained in section 2. H2O, NMR solvent (DMSO-d6), vacuum 
grease, and TMS are present in the spectrum. (A) Full spectrum, (B) aromatic 
region, (C) mixture of 2-5b and 2-5c 
 
6-(6-fluoro-1H-benzotriazol-1-yl)-2-nitropyridine 
 
 
Figure 77: 2-5b 
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Created simultaneously with 6-(5-fluoro-1H-benzotriazol-1-yl)-2-nitropyridine 
and assessed in the same manner. To fully characterize this compound, MS 
and 13C NMR are needed. Yield was not recorded for the fluorinated analogs. 
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Figure 78: 1H NMR in DMSO-d6 δ (ppm) 8.50 (1-H, dd), 8.30 (1H, d), 8.12 (1H, 
d), 8.11 (1H, t), 7.82 (1H, d), 7.74 (1H td). Coupling constants are measured in 
CDCl3 and explained in section 2. H2O, NMR solvent (DMSO-d6), vacuum 
grease, and TMS are present in the spectrum. Full spectrum, aromatic region, 
and an isomeric mixture of 2-5b and 2-5c are shown.  
H2O DMSO Vacuum Greasea TMS 
H2O DMSO Vacuum Greasea TMS 
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